Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05346640 · ClinicalTrials.gov registry record · NA
Augmenting Gait in a Population Exhibiting Foot Drop With Adaptive Functional Electrical Stimulation
A NA study of Foot Drop, sponsored by Cionic.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT05346640: Completed NA study of Foot Drop, sponsored by Cionic.
NCT05346640 is a NA study of Foot Drop that has completed, run by Cionic. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05346640, a NA study of Foot Drop, has completed, sponsored by Cionic.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this study is to investigate the effects of personalized, adaptive, current-steering functional electrical stimulation (FES) of the lower leg to improve gait in people with foot drop.
Primary Outcome
Dorsiflexion measured via inertial measurement unit (IMU) sensors placed on the foot and lower leg, measured in degrees. Heel strike is determined from pressure sensors in the shoe.
Conditions Studied
Interventions
- DEVICE Cionic Neural Sleeve
Study Locations (2)
California
- Cionic, Inc. - San Francisco
Ohio
- Cleveland State University - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-06-08 |
| Est. Completion | 2022-02-25 |
| Phase | NA |
What the finished NCT05346640 record still lists
NCT05346640 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Foot Drop appearing as the primary indexed condition, and to 1 intervention - of which Cionic Neural Sleeve is the first listed.
NCT05346640 reports a single indexed study location in California, Ohio.
Frequently Asked Questions
What is clinical trial NCT05346640 about?
NCT05346640 is a clinical study titled "Augmenting Gait in a Population Exhibiting Foot Drop With Adaptive Functional Electrical Stimulation". The objective of this study is to investigate the effects of personalized, adaptive, current-steering functional electrical stimulation (FES) of the lower leg to improve gait in people with foot drop.
What is the current status of trial NCT05346640?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-06-08. Estimated completion is 2022-02-25.
What conditions does trial NCT05346640 study?
This clinical trial studies the following conditions: Foot Drop.
What interventions are being tested in trial NCT05346640?
The interventions under investigation include: Cionic Neural Sleeve (DEVICE).
Who is sponsoring clinical trial NCT05346640?
This trial is sponsored by Cionic, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05346640 being conducted?
This trial has 2 study locations across California, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Foot Drop
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05346640's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI